Page last updated: 2024-11-05

xanthurenic acid and Psychotic Disorders

xanthurenic acid has been researched along with Psychotic Disorders in 2 studies

xanthurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by hydroxy groups at C-4 and C-8.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Curto, M1
Lionetto, L1
Fazio, F1
Corigliano, V1
Comparelli, A1
Ferracuti, S1
Simmaco, M1
Nicoletti, F1
Baldessarini, RJ1
Shilov, IuE1
Bezrukov, MV1

Reviews

1 review available for xanthurenic acid and Psychotic Disorders

ArticleYear
[Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2013, Issue:1

    Topics: Humans; Hydroxyindoleacetic Acid; Kynurenine; Mental Disorders; Psychotic Disorders; Tryptophan; Xan

2013

Other Studies

1 other study available for xanthurenic acid and Psychotic Disorders

ArticleYear
Serum xanthurenic acid levels: Reduced in subjects at ultra high risk for psychosis.
    Schizophrenia research, 2019, Volume: 208

    Topics: Adolescent; Adult; Disease Progression; Female; Humans; Hydroxyindoleacetic Acid; Kynurenic Acid; Ky

2019